Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision | ||
|
en:start [2025/08/22 15:08] Gianluca Frustagli |
en:start [2025/08/24 15:38] (current) Gianluca Frustagli "Project GENEVAX": fixed link to logos. |
||
|---|---|---|---|
| Line 237: | Line 237: | ||
| <wrap bigger>**GENEVAX Project**</wrap> | <wrap bigger>**GENEVAX Project**</wrap> | ||
| - | {{ :aree:fabiocell:genevax-loghi.png?350 |}} | + | {{ :recycler:20250823-fabiocell:genevax-loghi.png?350 |}} |
| - | In the context of the **POR FESR, Key Enabling Technologies (KETs)** calls, the FaBioCell cell factory has recently received a loan from **[[http://www.lazioinnova.it|Lazio Innova]]** for the **[[http://www.evvivax.com/index.php/13-research/67-from-genes-to-translational-vaccines-genevax|GENEVAX]]** project, developed in collaboration with **[[http://www.evvivax.com|EVVIVAX]]**, a biotech dedicated to immunotherapy in the veterinary field [[en:aree:fabiocell:ricerca#genevax_project|[read more...]]] | + | In the context of the **POR FESR, Key Enabling Technologies (KETs)** calls, the FaBioCell cell factory has recently received a loan from **[[http://www.lazioinnova.it|Lazio Innova]]** for the **[[http://www.evvivax.com/index.php/13-research/67-from-genes-to-translational-vaccines-genevax|GENEVAX]]** project, developed in collaboration with **[[http://www.evvivax.com|EVVIVAX]]**, a biotech dedicated to immunotherapy in the veterinary field [[en:recycler:20250823-fabiocell:ricerca#genevax_project|[read more...]]] |
| Line 592: | Line 592: | ||
| <wrap bigger>**GENEVAX Project**</wrap> | <wrap bigger>**GENEVAX Project**</wrap> | ||
| - | {{ :aree:fabiocell:genevax-loghi.png?350 |}} | + | {{ :recycler:20250823-fabiocell:genevax-loghi.png?350 |}} |
| - | In the context of the **POR FESR, Key Enabling Technologies (KETs)** calls, the FaBioCell cell factory has recently received a loan from **[[http://www.lazioinnova.it|Lazio Innova]]** for the **[[http://www.evvivax.com/index.php/13-research/67-from-genes-to-translational-vaccines-genevax|GENEVAX]]** project, developed in collaboration with **[[http://www.evvivax.com|EVVIVAX]]**, a biotech dedicated to immunotherapy in the veterinary field [[en:aree:fabiocell:ricerca#genevax_project|[read more...]]] | + | In the context of the **POR FESR, Key Enabling Technologies (KETs)** calls, the FaBioCell cell factory has recently received a loan from **[[http://www.lazioinnova.it|Lazio Innova]]** for the **[[http://www.evvivax.com/index.php/13-research/67-from-genes-to-translational-vaccines-genevax|GENEVAX]]** project, developed in collaboration with **[[http://www.evvivax.com|EVVIVAX]]**, a biotech dedicated to immunotherapy in the veterinary field [[en:recycler:20250823-fabiocell:ricerca#genevax_project|[read more...]]] |
